PDB Short entry for 4NAH HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-OCT-13 4NAH TITLE INHIBITORS OF 4-PHOSPHOPANTHETHEINE ADENYLYLTRANSFERASE (PPAT) COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHOPANTETHEINE ADENYLYLTRANSFERASE; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 SYNONYM: DEPHOSPHO-COA PYROPHOSPHORYLASE, PANTETHEINE-PHOSPHATE COMPND 5 ADENYLYLTRANSFERASE, PPAT; COMPND 6 EC: 2.7.7.3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STAPHYLOCOCCUS AUREUS; SOURCE 3 ORGANISM_TAXID: 196620; SOURCE 4 STRAIN: MW2; SOURCE 5 GENE: COAD, MW1007; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS PHOSPHOPANTHETHEINE ADENYLYLTRANSFERASE, PHOSPHOPANTHETHEINE, KEYWDS 2 TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.D.LAHIRI REVDAT 1 12-MAR-14 4NAH 0 JRNL AUTH B.L.DE JONGE,G.K.WALKUP,S.D.LAHIRI,H.HUYNH,G.NECKERMANN, JRNL AUTH 2 L.UTLEY,T.J.NASH,J.BROCK,M.SAN MARTIN,A.KUTSCHKE, JRNL AUTH 3 M.JOHNSTONE,V.LAGANAS,L.HAJEC,R.F.GU,H.NI,B.CHEN, JRNL AUTH 4 K.HUTCHINGS,E.HOLT,D.MCKINNEY,N.GAO,S.LIVCHAK,J.THRESHER JRNL TITL DISCOVERY OF INHIBITORS OF 4'-PHOSPHOPANTETHEINE JRNL TITL 2 ADENYLYLTRANSFERASE (PPAT) TO VALIDATE PPAT AS A TARGET FOR JRNL TITL 3 ANTIBACTERIAL THERAPY. JRNL REF ANTIMICROB.AGENTS CHEMOTHER. V. 57 6005 2013 JRNL REFN ISSN 0066-4804 JRNL PMID 24041904 JRNL DOI 10.1128/AAC.01661-13 REMARK 2 REMARK 2 RESOLUTION. 2.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0049 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 41.70 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 3 NUMBER OF REFLECTIONS : 42857 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.220 REMARK 3 R VALUE (WORKING SET) : 0.216 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2280 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.38 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3161 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.46 REMARK 3 BIN R VALUE (WORKING SET) : 0.2250 REMARK 3 BIN FREE R VALUE SET COUNT : 168 REMARK 3 BIN FREE R VALUE : 0.3480 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7724 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 396 REMARK 3 SOLVENT ATOMS : 78 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.03000 REMARK 3 B22 (A**2) : -0.06000 REMARK 3 B33 (A**2) : 0.03000 REMARK 3 B12 (A**2) : -0.00000 REMARK 3 B13 (A**2) : -0.03000 REMARK 3 B23 (A**2) : -0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.473 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.310 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.233 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.777 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.877 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8294 ; 0.014 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 7722 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11224 ; 1.888 ; 2.026 REMARK 3 BOND ANGLES OTHERS (DEGREES): 17868 ; 0.897 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 952 ; 6.928 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 354 ;36.315 ;24.237 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1506 ;18.113 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 42 ;17.711 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1204 ; 0.093 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 8962 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1756 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 180 ; 0.193 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): 1 ; 0.035 ; 0.200 REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 17 ; 0.289 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 28 ; 0.262 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 5 ; 0.162 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3826 ; 2.213 ; 3.665 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 3825 ; 2.214 ; 3.664 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4772 ; 3.309 ; 5.493 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4468 ; 2.404 ; 3.953 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 4NAH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-DEC-13. REMARK 100 THE RCSB ID CODE IS RCSB082956. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.07230 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45145 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.380 REMARK 200 RESOLUTION RANGE LOW (A) : 105.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.1 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.78 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 14% TO 19% POLYETHYLENE GLYCOL 3350 REMARK 280 (PEG 3350), 200 MM AMMONIUM SULFATE, 0.1M PROPIONIC ACID REMARK 280 CACODYLATE BIS-TRIS PROPANE BUFFER, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 52.68000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 26290 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 39000 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -118.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D, C, E, B, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 MET D 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OG1 THR A 104 OH TYR A 118 2.04 REMARK 500 O1B AGS A 201 O HOH A 313 2.05 REMARK 500 OG1 THR C 104 OH TYR C 118 2.09 REMARK 500 O2B AGS A 201 O38 2VJ A 203 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS D 36 N - CA - CB ANGL. DEV. = -11.3 DEGREES REMARK 500 LEU F 155 CA - CB - CG ANGL. DEV. = 17.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 41 -158.34 -63.19 REMARK 500 LYS A 43 37.35 88.68 REMARK 500 LYS A 61 -54.17 -26.11 REMARK 500 HIS A 62 0.11 -69.79 REMARK 500 ASN A 111 107.69 -166.86 REMARK 500 ARG A 140 21.06 45.56 REMARK 500 GLU B 2 -159.67 -87.81 REMARK 500 GLU B 44 110.52 11.40 REMARK 500 SER B 72 -107.90 100.09 REMARK 500 GLU C 2 170.71 -52.32 REMARK 500 LYS C 39 -88.07 -35.79 REMARK 500 ASN C 40 72.32 -119.88 REMARK 500 ASN C 111 104.53 -165.81 REMARK 500 ARG C 140 60.47 15.92 REMARK 500 PHE D 12 63.96 39.14 REMARK 500 ASP D 13 61.44 -118.49 REMARK 500 ASN D 40 75.34 51.92 REMARK 500 SER D 41 -149.61 -82.07 REMARK 500 LYS D 42 139.20 -176.87 REMARK 500 LYS D 43 77.50 89.45 REMARK 500 GLU D 44 145.71 158.88 REMARK 500 ASN D 111 128.01 -172.69 REMARK 500 GLU E 2 -127.30 -125.71 REMARK 500 PHE E 12 72.64 48.74 REMARK 500 LYS E 42 -25.73 78.35 REMARK 500 LYS E 43 179.59 -59.61 REMARK 500 THR E 46 -44.72 -7.69 REMARK 500 HIS E 62 10.12 -60.28 REMARK 500 PHE E 71 140.11 172.30 REMARK 500 SER E 72 -96.90 129.22 REMARK 500 SER F 41 125.45 -26.52 REMARK 500 ASN F 111 98.96 -174.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PHE B 71 SER B 72 39.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASP E 28 24.5 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AGS A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2VJ A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2VJ A 203 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AGS B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2VJ B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AGS C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AGS D 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2VJ D 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AGS E 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE AGS F 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2VJ F 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2VJ F 203 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4NAT RELATED DB: PDB REMARK 900 RELATED ID: 4NAU RELATED DB: PDB DBREF 4NAH A 1 160 UNP P63820 COAD_STAAW 1 160 DBREF 4NAH B 1 160 UNP P63820 COAD_STAAW 1 160 DBREF 4NAH C 1 160 UNP P63820 COAD_STAAW 1 160 DBREF 4NAH D 1 160 UNP P63820 COAD_STAAW 1 160 DBREF 4NAH E 1 160 UNP P63820 COAD_STAAW 1 160 DBREF 4NAH F 1 160 UNP P63820 COAD_STAAW 1 160 SEQRES 1 A 160 MET GLU HIS THR ILE ALA VAL ILE PRO GLY SER PHE ASP SEQRES 2 A 160 PRO ILE THR TYR GLY HIS LEU ASP ILE ILE GLU ARG SER SEQRES 3 A 160 THR ASP ARG PHE ASP GLU ILE HIS VAL CYS VAL LEU LYS SEQRES 4 A 160 ASN SER LYS LYS GLU GLY THR PHE SER LEU GLU GLU ARG SEQRES 5 A 160 MET ASP LEU ILE GLU GLN SER VAL LYS HIS LEU PRO ASN SEQRES 6 A 160 VAL LYS VAL HIS GLN PHE SER GLY LEU LEU VAL ASP TYR SEQRES 7 A 160 CYS GLU GLN VAL GLY ALA LYS THR ILE ILE ARG GLY LEU SEQRES 8 A 160 ARG ALA VAL SER ASP PHE GLU TYR GLU LEU ARG LEU THR SEQRES 9 A 160 SER MET ASN LYS LYS LEU ASN ASN GLU ILE GLU THR LEU SEQRES 10 A 160 TYR MET MET SER SER THR ASN TYR SER PHE ILE SER SER SEQRES 11 A 160 SER ILE VAL LYS GLU VAL ALA ALA TYR ARG ALA ASP ILE SEQRES 12 A 160 SER GLU PHE VAL PRO PRO TYR VAL GLU LYS ALA LEU LYS SEQRES 13 A 160 LYS LYS PHE LYS SEQRES 1 B 160 MET GLU HIS THR ILE ALA VAL ILE PRO GLY SER PHE ASP SEQRES 2 B 160 PRO ILE THR TYR GLY HIS LEU ASP ILE ILE GLU ARG SER SEQRES 3 B 160 THR ASP ARG PHE ASP GLU ILE HIS VAL CYS VAL LEU LYS SEQRES 4 B 160 ASN SER LYS LYS GLU GLY THR PHE SER LEU GLU GLU ARG SEQRES 5 B 160 MET ASP LEU ILE GLU GLN SER VAL LYS HIS LEU PRO ASN SEQRES 6 B 160 VAL LYS VAL HIS GLN PHE SER GLY LEU LEU VAL ASP TYR SEQRES 7 B 160 CYS GLU GLN VAL GLY ALA LYS THR ILE ILE ARG GLY LEU SEQRES 8 B 160 ARG ALA VAL SER ASP PHE GLU TYR GLU LEU ARG LEU THR SEQRES 9 B 160 SER MET ASN LYS LYS LEU ASN ASN GLU ILE GLU THR LEU SEQRES 10 B 160 TYR MET MET SER SER THR ASN TYR SER PHE ILE SER SER SEQRES 11 B 160 SER ILE VAL LYS GLU VAL ALA ALA TYR ARG ALA ASP ILE SEQRES 12 B 160 SER GLU PHE VAL PRO PRO TYR VAL GLU LYS ALA LEU LYS SEQRES 13 B 160 LYS LYS PHE LYS SEQRES 1 C 160 MET GLU HIS THR ILE ALA VAL ILE PRO GLY SER PHE ASP SEQRES 2 C 160 PRO ILE THR TYR GLY HIS LEU ASP ILE ILE GLU ARG SER SEQRES 3 C 160 THR ASP ARG PHE ASP GLU ILE HIS VAL CYS VAL LEU LYS SEQRES 4 C 160 ASN SER LYS LYS GLU GLY THR PHE SER LEU GLU GLU ARG SEQRES 5 C 160 MET ASP LEU ILE GLU GLN SER VAL LYS HIS LEU PRO ASN SEQRES 6 C 160 VAL LYS VAL HIS GLN PHE SER GLY LEU LEU VAL ASP TYR SEQRES 7 C 160 CYS GLU GLN VAL GLY ALA LYS THR ILE ILE ARG GLY LEU SEQRES 8 C 160 ARG ALA VAL SER ASP PHE GLU TYR GLU LEU ARG LEU THR SEQRES 9 C 160 SER MET ASN LYS LYS LEU ASN ASN GLU ILE GLU THR LEU SEQRES 10 C 160 TYR MET MET SER SER THR ASN TYR SER PHE ILE SER SER SEQRES 11 C 160 SER ILE VAL LYS GLU VAL ALA ALA TYR ARG ALA ASP ILE SEQRES 12 C 160 SER GLU PHE VAL PRO PRO TYR VAL GLU LYS ALA LEU LYS SEQRES 13 C 160 LYS LYS PHE LYS SEQRES 1 D 160 MET GLU HIS THR ILE ALA VAL ILE PRO GLY SER PHE ASP SEQRES 2 D 160 PRO ILE THR TYR GLY HIS LEU ASP ILE ILE GLU ARG SER SEQRES 3 D 160 THR ASP ARG PHE ASP GLU ILE HIS VAL CYS VAL LEU LYS SEQRES 4 D 160 ASN SER LYS LYS GLU GLY THR PHE SER LEU GLU GLU ARG SEQRES 5 D 160 MET ASP LEU ILE GLU GLN SER VAL LYS HIS LEU PRO ASN SEQRES 6 D 160 VAL LYS VAL HIS GLN PHE SER GLY LEU LEU VAL ASP TYR SEQRES 7 D 160 CYS GLU GLN VAL GLY ALA LYS THR ILE ILE ARG GLY LEU SEQRES 8 D 160 ARG ALA VAL SER ASP PHE GLU TYR GLU LEU ARG LEU THR SEQRES 9 D 160 SER MET ASN LYS LYS LEU ASN ASN GLU ILE GLU THR LEU SEQRES 10 D 160 TYR MET MET SER SER THR ASN TYR SER PHE ILE SER SER SEQRES 11 D 160 SER ILE VAL LYS GLU VAL ALA ALA TYR ARG ALA ASP ILE SEQRES 12 D 160 SER GLU PHE VAL PRO PRO TYR VAL GLU LYS ALA LEU LYS SEQRES 13 D 160 LYS LYS PHE LYS SEQRES 1 E 160 MET GLU HIS THR ILE ALA VAL ILE PRO GLY SER PHE ASP SEQRES 2 E 160 PRO ILE THR TYR GLY HIS LEU ASP ILE ILE GLU ARG SER SEQRES 3 E 160 THR ASP ARG PHE ASP GLU ILE HIS VAL CYS VAL LEU LYS SEQRES 4 E 160 ASN SER LYS LYS GLU GLY THR PHE SER LEU GLU GLU ARG SEQRES 5 E 160 MET ASP LEU ILE GLU GLN SER VAL LYS HIS LEU PRO ASN SEQRES 6 E 160 VAL LYS VAL HIS GLN PHE SER GLY LEU LEU VAL ASP TYR SEQRES 7 E 160 CYS GLU GLN VAL GLY ALA LYS THR ILE ILE ARG GLY LEU SEQRES 8 E 160 ARG ALA VAL SER ASP PHE GLU TYR GLU LEU ARG LEU THR SEQRES 9 E 160 SER MET ASN LYS LYS LEU ASN ASN GLU ILE GLU THR LEU SEQRES 10 E 160 TYR MET MET SER SER THR ASN TYR SER PHE ILE SER SER SEQRES 11 E 160 SER ILE VAL LYS GLU VAL ALA ALA TYR ARG ALA ASP ILE SEQRES 12 E 160 SER GLU PHE VAL PRO PRO TYR VAL GLU LYS ALA LEU LYS SEQRES 13 E 160 LYS LYS PHE LYS SEQRES 1 F 160 MET GLU HIS THR ILE ALA VAL ILE PRO GLY SER PHE ASP SEQRES 2 F 160 PRO ILE THR TYR GLY HIS LEU ASP ILE ILE GLU ARG SER SEQRES 3 F 160 THR ASP ARG PHE ASP GLU ILE HIS VAL CYS VAL LEU LYS SEQRES 4 F 160 ASN SER LYS LYS GLU GLY THR PHE SER LEU GLU GLU ARG SEQRES 5 F 160 MET ASP LEU ILE GLU GLN SER VAL LYS HIS LEU PRO ASN SEQRES 6 F 160 VAL LYS VAL HIS GLN PHE SER GLY LEU LEU VAL ASP TYR SEQRES 7 F 160 CYS GLU GLN VAL GLY ALA LYS THR ILE ILE ARG GLY LEU SEQRES 8 F 160 ARG ALA VAL SER ASP PHE GLU TYR GLU LEU ARG LEU THR SEQRES 9 F 160 SER MET ASN LYS LYS LEU ASN ASN GLU ILE GLU THR LEU SEQRES 10 F 160 TYR MET MET SER SER THR ASN TYR SER PHE ILE SER SER SEQRES 11 F 160 SER ILE VAL LYS GLU VAL ALA ALA TYR ARG ALA ASP ILE SEQRES 12 F 160 SER GLU PHE VAL PRO PRO TYR VAL GLU LYS ALA LEU LYS SEQRES 13 F 160 LYS LYS PHE LYS HET AGS A 201 31 HET 2VJ A 202 35 HET 2VJ A 203 35 HET AGS B 201 31 HET 2VJ B 202 35 HET AGS C 201 31 HET AGS D 201 31 HET 2VJ D 202 35 HET AGS E 201 31 HET AGS F 201 31 HET 2VJ F 202 35 HET 2VJ F 203 35 HETNAM AGS PHOSPHOTHIOPHOSPHORIC ACID-ADENYLATE ESTER HETNAM 2VJ 2-[(2-{(1S,2S)-2-[(3,4-DICHLOROBENZYL) HETNAM 2 2VJ CARBAMOYL]CYCLOHEXYL}-6-ETHYLPYRIMIDIN-4-YL)SULFANYL]- HETNAM 3 2VJ 1H-IMIDAZOLE-5-CARBOXYLIC ACID HETSYN AGS ATP-GAMMA-S; ADENOSINE 5'-(3-THIOTRIPHOSPHATE); HETSYN 2 AGS ADENOSINE 5'-(GAMMA-THIOTRIPHOSPHATE); ADENOSINE-5'- HETSYN 3 AGS DIPHOSPHATE MONOTHIOPHOSPHATE FORMUL 7 AGS 6(C10 H16 N5 O12 P3 S) FORMUL 8 2VJ 6(C24 H25 CL2 N5 O3 S) FORMUL 19 HOH *78(H2 O) HELIX 1 1 THR A 16 THR A 27 1 12 HELIX 2 2 SER A 48 LYS A 61 1 14 HELIX 3 3 LEU A 74 GLY A 83 1 10 HELIX 4 4 ALA A 93 ASN A 111 1 19 HELIX 5 5 SER A 129 TYR A 139 1 11 HELIX 6 6 PRO A 148 LYS A 160 1 13 HELIX 7 7 THR B 16 ASP B 28 1 13 HELIX 8 8 SER B 48 VAL B 60 1 13 HELIX 9 9 LEU B 74 GLY B 83 1 10 HELIX 10 10 ALA B 93 ASN B 111 1 19 HELIX 11 11 SER B 122 SER B 126 5 5 HELIX 12 12 SER B 129 TYR B 139 1 11 HELIX 13 13 PRO B 148 PHE B 159 1 12 HELIX 14 14 THR C 16 THR C 27 1 12 HELIX 15 15 ASP C 28 PHE C 30 5 3 HELIX 16 16 SER C 48 LYS C 61 1 14 HELIX 17 17 LEU C 74 VAL C 82 1 9 HELIX 18 18 ALA C 93 ASN C 111 1 19 HELIX 19 19 SER C 122 SER C 126 5 5 HELIX 20 20 SER C 129 TYR C 139 1 11 HELIX 21 21 PRO C 148 LYS C 160 1 13 HELIX 22 22 THR D 16 ASP D 28 1 13 HELIX 23 23 SER D 48 VAL D 60 1 13 HELIX 24 24 LEU D 74 GLY D 83 1 10 HELIX 25 25 ALA D 93 ASN D 111 1 19 HELIX 26 26 SER D 122 SER D 126 5 5 HELIX 27 27 SER D 129 ALA D 138 1 10 HELIX 28 28 PRO D 148 LYS D 160 1 13 HELIX 29 29 THR E 16 THR E 27 1 12 HELIX 30 30 ASP E 28 PHE E 30 5 3 HELIX 31 31 SER E 48 VAL E 60 1 13 HELIX 32 32 LEU E 74 GLY E 83 1 10 HELIX 33 33 ALA E 93 ASN E 111 1 19 HELIX 34 34 SER E 122 SER E 126 5 5 HELIX 35 35 SER E 129 TYR E 139 1 11 HELIX 36 36 PRO E 148 LYS E 157 1 10 HELIX 37 37 THR F 16 ASP F 28 1 13 HELIX 38 38 SER F 48 VAL F 60 1 13 HELIX 39 39 LEU F 74 GLY F 83 1 10 HELIX 40 40 ALA F 93 ASN F 111 1 19 HELIX 41 41 SER F 122 SER F 126 5 5 HELIX 42 42 SER F 129 TYR F 139 1 11 HELIX 43 43 PRO F 148 PHE F 159 1 12 SHEET 1 A 5 VAL A 66 PHE A 71 0 SHEET 2 A 5 GLU A 32 LEU A 38 1 N VAL A 35 O LYS A 67 SHEET 3 A 5 ILE A 5 PRO A 9 1 N ALA A 6 O HIS A 34 SHEET 4 A 5 THR A 86 LEU A 91 1 O ILE A 88 N VAL A 7 SHEET 5 A 5 GLU A 115 MET A 120 1 O LEU A 117 N ILE A 87 SHEET 1 B 5 VAL B 66 PHE B 71 0 SHEET 2 B 5 GLU B 32 LEU B 38 1 N VAL B 35 O LYS B 67 SHEET 3 B 5 ILE B 5 PRO B 9 1 N ALA B 6 O HIS B 34 SHEET 4 B 5 THR B 86 LEU B 91 1 O THR B 86 N VAL B 7 SHEET 5 B 5 GLU B 115 MET B 120 1 O LEU B 117 N ILE B 87 SHEET 1 C 5 VAL C 66 PHE C 71 0 SHEET 2 C 5 GLU C 32 LEU C 38 1 N VAL C 35 O HIS C 69 SHEET 3 C 5 ILE C 5 GLY C 10 1 N ALA C 6 O HIS C 34 SHEET 4 C 5 THR C 86 LEU C 91 1 O THR C 86 N VAL C 7 SHEET 5 C 5 GLU C 115 MET C 120 1 O LEU C 117 N ILE C 87 SHEET 1 D 5 VAL D 66 PHE D 71 0 SHEET 2 D 5 GLU D 32 LEU D 38 1 N VAL D 35 O LYS D 67 SHEET 3 D 5 ILE D 5 PRO D 9 1 N ILE D 8 O HIS D 34 SHEET 4 D 5 ALA D 84 LEU D 91 1 O ILE D 88 N VAL D 7 SHEET 5 D 5 GLU D 115 MET D 120 1 O LEU D 117 N ILE D 87 SHEET 1 E 5 VAL E 66 PHE E 71 0 SHEET 2 E 5 GLU E 32 LEU E 38 1 N VAL E 35 O LYS E 67 SHEET 3 E 5 ILE E 5 PRO E 9 1 N ALA E 6 O HIS E 34 SHEET 4 E 5 ALA E 84 LEU E 91 1 O ILE E 88 N VAL E 7 SHEET 5 E 5 GLU E 115 MET E 120 1 O LEU E 117 N ILE E 87 SHEET 1 F 5 VAL F 66 PHE F 71 0 SHEET 2 F 5 GLU F 32 LEU F 38 1 N ILE F 33 O LYS F 67 SHEET 3 F 5 ILE F 5 PRO F 9 1 N ALA F 6 O HIS F 34 SHEET 4 F 5 THR F 86 LEU F 91 1 O ILE F 88 N VAL F 7 SHEET 5 F 5 GLU F 115 MET F 120 1 O LEU F 117 N ILE F 87 CISPEP 1 ASP A 13 PRO A 14 0 -0.33 CISPEP 2 GLU A 44 GLY A 45 0 -20.29 CISPEP 3 GLY A 45 THR A 46 0 0.61 CISPEP 4 ASP B 13 PRO B 14 0 -1.48 CISPEP 5 ASP C 13 PRO C 14 0 -5.58 CISPEP 6 ASP D 13 PRO D 14 0 3.01 CISPEP 7 GLU D 44 GLY D 45 0 -14.81 CISPEP 8 GLY D 45 THR D 46 0 -27.73 CISPEP 9 ASP E 13 PRO E 14 0 -3.86 CISPEP 10 PHE E 71 SER E 72 0 3.62 CISPEP 11 ASP F 13 PRO F 14 0 -1.67 SITE 1 AC1 19 SER A 11 PHE A 12 GLY A 18 HIS A 19 SITE 2 AC1 19 ILE A 22 ARG A 89 GLY A 90 ARG A 92 SITE 3 AC1 19 ASP A 96 GLU A 100 SER A 121 TYR A 125 SITE 4 AC1 19 ILE A 128 SER A 129 SER A 130 SER A 131 SITE 5 AC1 19 2VJ A 203 HOH A 302 HOH A 313 SITE 1 AC2 13 GLU A 135 VAL A 136 TYR A 139 HOH A 301 SITE 2 AC2 13 CYS C 36 LYS C 43 GLY C 73 LEU C 74 SITE 3 AC2 13 LEU C 75 ARG C 89 TYR C 99 ASN C 107 SITE 4 AC2 13 HOH C 301 SITE 1 AC3 17 PRO A 9 SER A 11 CYS A 36 VAL A 37 SITE 2 AC3 17 LEU A 38 GLY A 73 LEU A 75 ARG A 89 SITE 3 AC3 17 TYR A 99 MET A 106 ASN A 107 AGS A 201 SITE 4 AC3 17 HOH A 304 HOH A 306 GLU B 135 TYR B 139 SITE 5 AC3 17 HOH B 307 SITE 1 AC4 15 SER B 11 PHE B 12 GLY B 18 HIS B 19 SITE 2 AC4 15 ARG B 89 GLY B 90 ARG B 92 GLU B 100 SITE 3 AC4 15 SER B 121 TYR B 125 ILE B 128 SER B 129 SITE 4 AC4 15 SER B 130 SER B 131 HOH B 312 SITE 1 AC5 13 PRO B 9 CYS B 36 VAL B 37 LEU B 38 SITE 2 AC5 13 GLY B 73 LEU B 74 LEU B 75 ARG B 89 SITE 3 AC5 13 TYR B 99 MET B 106 ASN B 107 HOH B 301 SITE 4 AC5 13 GLU C 135 SITE 1 AC6 17 PRO C 9 SER C 11 PHE C 12 GLY C 18 SITE 2 AC6 17 HIS C 19 ILE C 22 ARG C 89 GLY C 90 SITE 3 AC6 17 ARG C 92 GLU C 100 SER C 121 TYR C 125 SITE 4 AC6 17 ILE C 128 SER C 129 SER C 130 SER C 131 SITE 5 AC6 17 HOH C 302 SITE 1 AC7 18 PRO D 9 SER D 11 PHE D 12 GLY D 18 SITE 2 AC7 18 HIS D 19 ILE D 22 ARG D 89 GLY D 90 SITE 3 AC7 18 ARG D 92 GLU D 100 SER D 121 TYR D 125 SITE 4 AC7 18 ILE D 128 SER D 129 SER D 130 SER D 131 SITE 5 AC7 18 HOH D 303 HOH D 305 SITE 1 AC8 12 PRO D 9 GLY D 10 CYS D 36 VAL D 37 SITE 2 AC8 12 GLY D 73 LEU D 75 ARG D 89 TYR D 99 SITE 3 AC8 12 MET D 106 ASN D 107 HOH D 301 GLU E 135 SITE 1 AC9 16 SER E 11 PHE E 12 GLY E 18 HIS E 19 SITE 2 AC9 16 ARG E 89 GLY E 90 ARG E 92 ASP E 96 SITE 3 AC9 16 GLU E 100 SER E 121 TYR E 125 ILE E 128 SITE 4 AC9 16 SER E 129 SER E 130 SER E 131 HOH E 303 SITE 1 BC1 15 GLY F 10 SER F 11 PHE F 12 GLY F 18 SITE 2 BC1 15 HIS F 19 ILE F 22 ARG F 89 GLY F 90 SITE 3 BC1 15 ARG F 92 SER F 121 TYR F 125 ILE F 128 SITE 4 BC1 15 SER F 129 SER F 130 SER F 131 SITE 1 BC2 10 PRO E 9 CYS E 36 GLY E 73 LEU E 75 SITE 2 BC2 10 TYR E 99 LEU E 103 ASN E 107 GLU F 135 SITE 3 BC2 10 VAL F 136 TYR F 139 SITE 1 BC3 12 GLU D 135 TYR D 139 PRO F 9 CYS F 36 SITE 2 BC3 12 GLY F 73 LEU F 74 LEU F 75 ARG F 89 SITE 3 BC3 12 TYR F 99 GLU F 100 ASN F 107 HOH F 302 CRYST1 68.476 105.360 79.980 90.00 94.69 90.00 P 1 21 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014604 0.000000 0.001198 0.00000 SCALE2 0.000000 0.009491 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012545 0.00000